{"id":756488,"date":"2023-05-09T09:23:29","date_gmt":"2023-05-09T13:23:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-ranks-first-in-overall-corporate-reputation-by-u-s-patient-advocacy-groups\/"},"modified":"2023-05-09T09:23:29","modified_gmt":"2023-05-09T13:23:29","slug":"horizon-therapeutics-plc-ranks-first-in-overall-corporate-reputation-by-u-s-patient-advocacy-groups","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/horizon-therapeutics-plc-ranks-first-in-overall-corporate-reputation-by-u-s-patient-advocacy-groups\/","title":{"rendered":"Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups"},"content":{"rendered":"

<\/p>\n

Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by U.S. Patient Advocacy Groups<\/b><\/p>\n

DUBLIN–(BUSINESS WIRE<\/a>)–
\nHorizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among U.S. patient groups who reported working with, or who were familiar with the company. The results are based on PatientView\u2019s annual survey of 361 patient groups who evaluated 41 pharmaceutical and biotechnology companies across 14 individual indicators.<\/p>\n

\nPatient groups who worked with Horizon also ranked the company first in 11 of the 14 indicators<\/a> such as acting with integrity, employing a strong patient-centric approach, providing high-quality information for patients and ensuring that more patients get access to medicines.<\/p>\n

\n\u201cFor many years we have engaged with patient communities across the United States and are constantly learning from the approach that advocacy groups take to supporting the needs of people living with some of the most difficult diseases,\u201d said Matt Flesch, vice president, product communications and patient advocacy, Horizon. \u201cIt means a great deal to all of us throughout the company that these groups value our approach to collaborating with patient advocates, providing support and interacting with the community.\u201d<\/p>\n

\nPatient groups were given the opportunity to comment anonymously as part of the report and when discussing companies acting with integrity, one responder from an international scleroderma patient group wrote: \u201cI have been very impressed with Horizon\u2019s clear support of non-profit and patient-centered events. I think that being out there with the communities, helping to host events and having pharma representatives really show that they are there because they care, and not just because it\u2019s their job, that is very important.\u201d<\/p>\n

Horizon\u2019s Commitment to Patients and their Advocates<\/b><\/p>\n